Adjuvant Chemotherapy with Vinblastine and Bleomycin in Stage B Nonseminomatous Germ Cell Tumors of the Testis
- 1 October 1982
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 128 (4) , 712-714
- https://doi.org/10.1016/s0022-5347(17)53150-x
Abstract
Between 1974 and 1980, 48 lymph node dissections were done for nonseminomatous tumors. Of 23 patients with pathologic stage A disease 1 (4%) suffered recurrence but is free of disease after chemotherapy and pulmonary resection. All 23 patients (100%) are free of disease. Adjuvant chemotherapy with high dose vinblastine and constant infusion of bleomycin was given in 25 patients with stge B disease and none had maintenance chemotherapy. Of these 25 patients 2 (8%) had evidence of recurrent disease after adjuvant chemotherapy and both are free of disease after further chemotherapy, which included cis-platinum. One patient died after a second primary embryonal carcinoma developed in the remaining testis 3 years after the initial tumor. Twenty-four of the 25 patients with stage B tumor (96%) are free of disease 15 mo. to > 7 yr after therapy.This publication has 5 references indexed in Scilit:
- Guest Editorial: Testicular CancerJournal of Urology, 1981
- Adjuvant Chemotherapy in Non-Seminomatous Testis Cancer: “Mini-Vab” Regimen: Long-Term FollowupJournal of Urology, 1981
- Dose: A critical factor in cancer chemotherapyThe American Journal of Medicine, 1980
- Adjuvant Therapy of Testis Cancer: The Role of Vinblastine and BleomycinJournal of Urology, 1980
- Vinblastine, bleomycin and cis-diamminedichloroplatinum in the treatment of advanced testicular carcinoma: Possible importance of longer induction and shorter maintenance schedulesThe American Journal of Medicine, 1980